Patients With CLL Could Also Face Autoimmune Complications, Expert Says
Autoimmune diseases in patients with CLL are separate from CLL, which calls for different treatments.
Stay updated with breaking news from Cll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Autoimmune diseases in patients with CLL are separate from CLL, which calls for different treatments.
Jennifer A. Woyach, MD, elucidates the updated results generated from a phase 2 study of venetoclax monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia (CLL) whose disease progressed on a prior B-cell receptor inhibitor, expanded on key findings from a genomic analysis from the study, and highlighted what these findings could mean for the CLL treatment paradigm.
The Chronic Lymphocytic Leukemia (CLL) condition center is a comprehensive resource for cancer news & oncologist insights on CLL Read more about cancer at CURE.
After receiving two cancer diagnoses, I became more vigilant about my health — especially during the COVID-19 pandemic.
Fewer patients with chronic lymphocytic leukemia experienced cardiac toxicities with Calquence than those treated with Imbruvica, research showed.